News France's Doctolib is new digital health unicorn Doctolib, the largest digital health service in Europe, has raised 150 million euros in a funding round, valuing it at over a billion euros.
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
